| Literature DB >> 25410823 |
P Ciliberti1, I McLeod, F Cairello, J P Kaski, M Fenton, A Giardini, J Marek.
Abstract
Although exercise stress echocardiography (ESE) is a well-validated technique in adult population, its use in children is quite limited. We aimed to assess the feasibility, the safety and the reproducibility of ESE, using on-line scanning in semi-supine cyclo-ergometer protocol in a large pediatric population. Between July 2008 and January 2013, 42 patients (mean age 14 ± 3) were evaluated with a bicycle ESE performing 50 studies. ESE was successfully performed and well tolerated by all patients. None of the patients presented with adverse effects of stress-induced ischemia. HR was 82 ± 13 at rest, and 153 ± 19.1 during peak exercise. Among 544 views analyzed for grading of image quality, the visualization was optimal in 473 (87 %), suboptimal in 39, and inadequate in 32 (6 %). 37 tests were performed in patients with congenital or acquired coronary abnormality. Regional wall motion abnormalities (RWMA) were revealed in nine cases (24 %). The agreement between the two different observers showed a K index of 0.7276 (95 % CI 0.6497-0.8055) for the image quality and a K index of 0.5125 (95 % CI 0.4782-0.5468) for the RWMA analysis. Among ten patients with hypertrophic cardiomyopathy, we were able to demonstrate the new comparison of significant left ventricular outflow tract gradient (≥30 mmHg) during exercise in three patients (30 %). Bicycle stress echocardiography performed by on-line scanning during exercise is a feasible, safe, and reproducible modality in children. Further data to assess its diagnostic accuracy are, however, needed. Stress echocardiography provides a dynamic assessment of the myocardial structure and function under conditions of physiologic or pharmacologic stress.Entities:
Mesh:
Year: 2014 PMID: 25410823 PMCID: PMC4335126 DOI: 10.1007/s00246-014-1058-4
Source DB: PubMed Journal: Pediatr Cardiol ISSN: 0172-0643 Impact factor: 1.655
Main clinical characteristics and results of the entire cohort of test performed
| Total, | |
|---|---|
| Male sex, | 28 (56 %) |
| Age at exam (year) | 14 ± 3 |
| BSA | 1.4 ± 0.5 |
| Indication, | |
| Coronary artery disease detection | 37 (74 %) |
| HCM | 10 (20 %) |
| Other | 3 (6 %) |
| Patients on medication, | 11 (22 %) |
| Beta blockers | 7 (14 %) |
| Calcium channel blockers | 4 (8 %) |
| ACE inhibitor | 2 (4 %) |
| Termination due to muscular exhaustion, | 50 (100 %) |
| ECG abnormalities during stress, | 5 (10 %) |
| Arrhythmia, | 0 (0 %) |
| Symptoms | 2 (4 %) |
| Rest HR (bpm) | 82 ± 13.6 |
| Peak HR (bpm) | 153.4 ± 19.7 |
Main clinical characteristics and results of the tests performed for detection of coronary abnormalities
| Total, | |
|---|---|
| Male sex, | 22 (59 %) |
| Age at exam (year) | 13.6 ± 3 |
| BSA | 1.4 ± 0.5 |
| Indications | |
| Transition to adult clinic | 7 (19 %) |
| Chest pain/clinical deterioration | 7 (19 %) |
| Follow-up | 13 (35 %) |
| Coronary disease previously found at cath/MRI | 10 (27 %) |
| Diagnosis | |
| TGS S/P ASO | 9 (24 %) |
| Kawasaki disease | 7 (19 %) |
| Heart transplant | 11 (30 %) |
| Congenital coronary abnormality | 9 (24 %) |
| Other | 1 (3 %) |
| Patient on medication, | 2 (6 %) |
| Beta blockers | 0 (0 %) |
| Calcium channel blockers | 0 (0 %) |
| Ace inhibitor | 2 (6 %) |
| Termination due to muscular exhaustion, | 37 (100 %) |
| ECG abnormalities during stress, | 3 (8 %) |
| Arrhythmia, | 0 (0 %) |
| Symptoms | 1 (3 %) |
| Rest HR (bpm) | 87 ± 12.2 |
| Peak HR (bpm) | 155.7 ± 17.9 |
| Coronary angiograms available, | 20 (54 %) |
| Cardiac MRI available, | 21 (57 %) |
| Coronary angio or MRI available | 26 (70 %) |
Systematic description of the nine cases with evidence of RWMA during ESE
| Patient | Diagnosis | RWMA at rest | RWMA at low exercise | RWMA at peak exercise | RWMA at recovery | Coronary stenosis >70 % at cath | LG enhancement |
|---|---|---|---|---|---|---|---|
| 1 | TGA S/P ASO | + | + | – | + | – | – |
| 2 | HTx | + | – | – | + | + | / |
| 3 | CCA | – | + | + | – | / | / |
| 4 | HTx | + | + | – | + | – | / |
| 5 | HTx | + | + | + | + | + | + |
| 6 | HTx | + | + | + | + | + | + |
| 7 | CCA | + | + | + | + | – | – |
| 8 | TGA S/P ASO | + | + | + | + | – | – |
| 9 | TGA S/P ASO | + | + | + | + | + | – |
+positive, −negative, /not performed, CCA congenital coronary abnormality, TGA transposition of the great arteries, ASO arterial switch operation, HTx heart transplant
Main clinical characteristics and results of the tests performed in patients with HCM
| Total, | |
|---|---|
| Male sex, | 5 (50 %) |
| Age at exam (year) | 14.6 ± 3.6 |
| BSA | 1.3 ± 0.5 |
| Indications | |
| Exertional chest pain | 7 (70 %) |
| Exertional presyncope | 2 (20 %) |
| Exercise-induced fatigue | 1 (10 %) |
| Medication | 9 (90 %) |
| Beta blocker | 7 (77 %) |
| CCBs | 4 (44 %) |
| Termination due to muscular exhaustion, | 10 (100 %) |
| ECG abnormalities during stress, | 2 (20 %) |
| Arrhythmia, | 0 (0 %) |
| Symptoms | 1 (10 %) |
| Resting HR (bpm) | 74.1 ± 14.2 |
| Peak HR (bpm) | 134.3 ± 14.9 |
| LVOT gradient at rest, mmHg | 22.5 ± 11.2 |
| LVOT gradient at peak exercise, mmHg | 39.8 ± 30.5 |
| LVOT gradient at rest ≥30 mmHg, | 2 (20 %) |
| LVOT gradient ≥30 mmHg at peak exercise, | 5 (50 %) |
CCBs calcium channel blockers, LVOT left ventricle outflow tract